CME Group Inc. $CME Shares Bought by Tidal Investments LLC

Tidal Investments LLC boosted its holdings in shares of CME Group Inc. (NASDAQ:CME) by 1.2% in the 2nd quarter, Holdings Channel reports. The firm owned 161,957 shares of the financial services provider’s stock after buying an additional 1,851 shares during the period. Tidal Investments LLC’s holdings in CME Group were worth $35,765,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Van Hulzen Asset Management LLC boosted its stake in shares of CME Group by 10.9% during the 2nd quarter. Van Hulzen Asset Management LLC now owns 31,062 shares of the financial services provider’s stock worth $6,860,000 after acquiring an additional 3,041 shares in the last quarter. National Pension Service lifted its holdings in shares of CME Group by 4.4% during the second quarter. National Pension Service now owns 770,671 shares of the financial services provider’s stock valued at $170,187,000 after purchasing an additional 32,769 shares during the last quarter. BlueCrest Capital Management Ltd acquired a new position in shares of CME Group in the 2nd quarter valued at $2,208,000. WINTON GROUP Ltd increased its stake in CME Group by 120.7% in the 2nd quarter. WINTON GROUP Ltd now owns 132,440 shares of the financial services provider’s stock worth $29,247,000 after purchasing an additional 72,440 shares in the last quarter. Finally, Engineers Gate Manager LP purchased a new position in CME Group in the 2nd quarter worth about $18,606,000. 87.75% of the stock is currently owned by institutional investors.

CME Group Trading Down 1.3%

NASDAQ:CME opened at $274.70 on Thursday. The stock has a market cap of $98.78 billion, a PE ratio of 23.30, a price-to-earnings-growth ratio of 3.29 and a beta of 0.24. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The stock’s 50-day moving average is $262.03 and its two-hundred day moving average is $277.67.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. The business had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The firm’s revenue was up .8% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.96 earnings per share. As a group, equities research analysts forecast that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be paid a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group’s dividend payout ratio is currently 44.11%.

Insider Transactions at CME Group

In related news, Director William Shepard bought 325 shares of the business’s stock in a transaction on Thursday, June 25th. The stock was bought at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the transaction, the director directly owned 260,442 shares in the company, valued at $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.30% of the stock is currently owned by insiders.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Shareholder distribution: CME is scheduled to distribute approximately $467 million in dividends on September 25, reinforcing its appeal to income-oriented investors and highlighting the exchange operator’s strong cash-generation profile. CME Group’s $467 Million Dividend: What Shareholders Collect Sept. 25
• Positive Sentiment: Product expansion: CME’s new single-stock futures offer investors leveraged and capital-efficient exposure to individual equities. The product broadens CME’s equity derivatives lineup and could create additional trading volume and fee revenue over time. CME’s New Single Stock Futures: What Are The Advantages Vs. Stocks?
• Positive Sentiment: European market entry: CME plans to enter the European dairy market through a deal involving EEX, expanding its addressable market and potentially improving its international commodities presence. CME Group to enter European dairy market through EEX deal
• Neutral Sentiment: Leadership succession: CME named insider Jack Tobin as CFO, succeeding Lynne Fitzpatrick, who is expected to become CEO in March 2027. The planned internal transition may provide continuity, although investors could monitor execution during the leadership change. CME Group names Jack Tobin as CFO
• Neutral Sentiment: Interest-rate backdrop: Reports that Federal Reserve Chair Warsh favors rate hikes, while the Treasury considers buying longer-maturity debt, point to continued uncertainty over rates, inflation and bond-market conditions. These factors can affect CME’s interest-rate and fixed-income trading volumes. Fed and Treasury at Odds
• Negative Sentiment: Regulatory litigation: The Hyperliquid Policy Center filed an amicus brief urging dismissal of CME’s lawsuit against the CFTC. The development adds uncertainty to CME’s regulatory position and could weigh on sentiment surrounding its digital-asset and derivatives initiatives. Hyperliquid Policy Center Files Amicus Brief Urging Dismissal of CME’s Suit Against CFTC

Analysts Set New Price Targets

CME has been the subject of a number of analyst reports. The Goldman Sachs Group reduced their price objective on shares of CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a research note on Tuesday, June 30th. Keefe, Bruyette & Woods upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price target on the stock in a report on Thursday, June 18th. Rothschild & Co Redburn upgraded shares of CME Group from a “neutral” rating to a “buy” rating and upped their price target for the company from $316.00 to $323.00 in a research report on Thursday, June 11th. Wall Street Zen raised shares of CME Group from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 29th. Finally, Raymond James Financial reiterated an “outperform” rating and set a $320.00 price objective on shares of CME Group in a research report on Thursday, July 2nd. Nine research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, CME Group presently has an average rating of “Hold” and a consensus target price of $289.75.

CME Group Profile

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for a broad range of financial and commodity products. Its exchange platforms enable participants to manage risk, discover prices and gain exposure to asset classes including interest rates, equity indexes, foreign exchange, energy, metals, agricultural commodities and digital assets.

The company’s principal marketplaces include CME, CBOT, NYMEX and COMEX. Products are offered through futures and options contracts, with electronic trading available through CME Globex as well as exchange-based and privately negotiated transactions.